Rapid advances in imaging technologies and gene transfer strategies offer a
great opportunity to optimize clinical trials of human gene therapy. Repor
ter genes are emerging as very powerful tools to monitor the delivery, magn
itude, and time variation of therapeutic gene transfer in vivo. Several rep
orter genes, such as the herpes simplex virus type 1 thymidine kinase, the
dopamine type 2 receptor, and the somatostatin receptor type 2, are current
ly being successfully used with gamma camera, single photon emission comput
ed tomography, and positron emission tomography imaging. These reporter gen
es can be coupled with a therapeutic gene of interest to indirectly monitor
the expression of the therapeutic gene. Finally, applications of the repor
ter gene technology to other areas, such as cell trafficking studies and tr
ansgenic animal models, are now possible. Copyright (C) 2001 by W.B. Saunde
rs Company.